| Date | Subject |
| 01/31/2012 04:32:28 PM | |
| Flexible Sigmoidoscopy Shown to Increase Detection of Colorectal Cancer |
| 01/31/2012 04:19:14 PM | |
| Technique Provides New Option for Breast Reconstruction After Radiation Therapy |
| 01/31/2012 03:29:23 PM | |
| Prostate Size May Help Predict Cancer Severity |
| 01/30/2012 06:21:31 PM | |
| CT Shows Unreliability in Assessing Cartilage Invasion From Advanced Laryngeal Carcinoma: Presented at MHNCS |
| 01/30/2012 06:11:42 PM | |
| Oral Temperature Changes May Predict Mucositis Severity With Head and Neck Cancer Treatment: Presented at MHNCS |
| 01/30/2012 05:43:24 PM | |
| Genetic Risk Factors for Acute Lymphoblastic Leukaemia Are More Common in Latino Children |
| 01/30/2012 03:21:44 PM | |
| Smokers With Barrett’s Oesophagus are at High Risk of Developing Oesophageal Cancer |
| 01/30/2012 03:16:06 PM | |
| Four-Week Vaccination Regimen Knocks Out Early Breast Cancer Tumours |
| 01/30/2012 03:11:25 PM | |
| PET/CT Useful in Detecting Post-treatment Cancer Recurrence, but False-Positive Rate Is High: Presented at MHNCS |
| 01/30/2012 12:15:02 PM | |
| FDA Approves Vismodegib for Locally Advanced Basal Cell Carcinoma |
| 01/30/2012 12:12:09 PM | |
| HIV-Positive Patients Show Poorer Response to Head and Neck Cancer Treatments: Presented at MHNCS |
| 01/30/2012 11:39:40 AM | |
| Osteoradionecrosis Remains a Chronic Complication of Radiation Therapy for Head and Neck Cancers: Presented at MHNCS |
| 01/27/2012 04:20:55 PM | |
| CD4 Levels Can Predict Laryngeal Cancer Treatment Response: Presented at MHNCS |
| 01/27/2012 04:19:04 PM | |
| Diagnostic Test Could Revolutionise Care of Patients With Gliomas |
| 01/27/2012 04:08:47 PM | |
| HPV Virus 3 Times More Common in Men Than Women: Presented at MHNCS |
| 01/27/2012 04:01:08 PM | |
| Genetic Variation Linked to Bisphosphonate-Related Osteonecrosis of the Jaw |
| 01/27/2012 02:40:36 PM | |
| FDA Approves Axitinib for Advanced Renal Cell Carcinoma |
| 01/27/2012 01:02:33 PM | |
| Chemoradiation Improves Outcomes in a Subset of Patients With Head and Neck Cancer: Presented at MHNCS |
| 01/26/2012 03:55:00 PM | |
| New Lung Cancer Assay Better Than Existing Methods at Predicting Survival After Surgery |
| 01/26/2012 03:38:11 PM | |
| New Lung Cancer Assay Better Than Existing Methods at Predicting Survival After Surgery |
| 01/25/2012 04:32:15 PM | |
| Brachytherapy Has Reduced Mortality Rates in Patients With High-Risk Prostate Cancer |
| 01/25/2012 03:05:32 PM | |
| HPV Vaccine Does Not Trigger Autoimmune Conditions |
| 01/24/2012 04:06:56 PM | |
| BRCA Gene Mutation Impacts Survival of Patients With Epithelial Ovarian Cancer |
| 01/24/2012 01:28:40 PM | |
| Dutasteride Reduces Need for Aggressive Therapy in Men With Low-Risk Prostate Cancer |
| 01/24/2012 01:11:21 PM | |
| Emergent Presentation of Colon Cancer Does Not Preclude Patients From Receiving Curative Therapy: Presented at ASCO-GI |
| 01/24/2012 01:08:34 PM | |
| Surgery for Late-Stage Gastric Cancer Has Decreased, May Reflect Decline in Survival: Presented at ASCO-GI |
| 01/23/2012 06:26:29 PM | |
| More Extensive Lymph Node Dissection in Gastric Cancer Feasible Using Laparoscopic Techniques: Presented at ASCO-GI |
| 01/23/2012 03:14:41 PM | |
| Study of Regorafenib Meets Endpoint of Improving Survival in Metastatic Colorectal Cancer: Presented at ASCO-GI |
| 01/23/2012 03:08:46 PM | |
| Laparoscopic Gastrectomy Safe, Feasible for Gastric Adenocarcinoma: Presented at ASCO-GI |
| 01/23/2012 02:55:43 PM | |
| Investigative Oral Taxane Shows Promise in the Treatment of Gastro-oesophageal Cancer: Presented at ASCO-GI |
| 01/23/2012 02:49:36 PM | |
| Early-Stage Oesophageal Cancer Appears Treatable Without Open Surgery: Presented at ASCO-GI |
| 01/23/2012 12:54:47 PM | |
| Extended Lymphadenectomy Does Not Influence Survival in Oesophageal, Gastric Cancer: Presented at ASCO-GI |
| 01/23/2012 12:52:32 PM | |
| Complications, Comorbidities Occur Often Following Therapy for Gastric Cancer: Presented at ASCO-GI |
| 01/23/2012 12:48:11 PM | |
| Adding Everolimus to Best Supportive Care Fails to Improve Survival in Advanced Gastric Cancer: Presented at ASCO-GI |
| 01/20/2012 03:39:35 PM | |
| FDA’s Guidance on Use of ESAs for Patients With Kidney Disease Fall Short, Say Experts |
| 01/20/2012 12:40:02 PM | |
| Duration of RBC Storage Does Not Affect Pulmonary or Coagulation Status |
| 01/19/2012 05:40:35 PM | |
| Genetic Abnormality Predicts Benefit From Treatment for a Rare Brain Tumour |
| 01/19/2012 11:52:05 AM | |
| Novel Test Offers Greater Accuracy in Early Detection of Colorectal Cancer |
| 01/18/2012 04:20:45 PM | |
| Novel Gene Mutations Associated With Bile Duct Cancer |
| 01/18/2012 04:01:07 PM | |
| Researchers Find Link Between TB, Gene Mutation That Causes Lung Cancer |
| 01/18/2012 10:53:17 AM | |
| FDA Approves Glucarpidase to Treat Patients With Toxic Methotrexate Levels |
| 01/16/2012 04:51:16 PM | |
| Studies Help Clarify the Role of Lapatinib, Trastuzumab in HER2-Positive Breast Cancer |
| 01/16/2012 04:22:18 PM | |
| Eating Problems, Pain Most Prevalent Problems of Head and Neck Cancer Survivors |
| 01/16/2012 01:20:28 PM | |
| New Indicator May Help ID Patients With Increased Risk From Throat Cancer |
| 01/13/2012 02:19:23 PM | |
| Personalised Gene Therapies May Increase Survival in Patients With Brain Cancer |
| 01/13/2012 02:12:47 PM | |
| NICE Recommends New Treatment for Chronic Myeloid Leukaemia |
| 01/13/2012 12:44:35 PM | |
| FDA Adds Boxed Warning to Brentuximab Vedotin Label, New Contraindication |
| 01/12/2012 12:59:18 PM | |
| Chemotherapy May Influence Leukaemia Relapse |
| 01/11/2012 05:59:32 PM | |
| Researchers Find First Major Gene Mutation Associated With Hereditary Prostate Cancer |
| 01/11/2012 03:34:49 PM | |
| Pre-Cancerous Markers Identified in Airway Epithelium Cells of Healthy Smokers |
| 01/09/2012 03:33:52 PM | |
| Dabigatran Associated With Increased Risk of Acute Coronary Events |
| 01/09/2012 02:57:38 PM | |
| Preventive Haemophilia A Treatment Reduces Annual Bleeding Events, Frequency of Infusions |
| 01/06/2012 02:50:17 PM | |
| Researchers ID Malignancy-Risk Gene Signature for Early-Stage NSCLC |
| 01/05/2012 04:35:23 PM | |
| Studies Show Proton Therapy Effective for the Treatment of Prostate Cancer |
| 01/05/2012 04:14:54 PM | |
| New Drug Screening IDs Agents With Anti-Cancer Activity in Thyroid Cancer Cells |
| 01/04/2012 03:56:02 PM | |
| Simple Online Tool to Aid GPs in Early Ovarian Cancer Diagnosis |
| 01/04/2012 12:53:01 PM | |
| Anti-Oestrogen Therapy May Decrease Risk for Melanoma |
| 12/29/2011 11:36:59 AM | |
| Gene Identified in Increasing Pancreatic Cancer Risk |
| 12/29/2011 11:33:36 AM | |
| Bevacizumab Slows Ovarian Cancer Progression, May Improve Survival |
| 12/28/2011 02:54:35 PM | |
| Analysis Does Not Support CYP2C19 Genotyping Before Use of Clopidogrel |
| 12/23/2011 11:29:32 AM | |
| Correction of Anaemia After Kidney Transplant Reduces Progression of Allograft Nephropathy |
| 12/20/2011 03:44:15 PM | |
| Aflibercept Reduces Formation of Malignant Ascites in Patients With Ovarian Cancer |
| 12/20/2011 03:09:16 PM | |
| Removal of Lymph Nodes During Surgery for Thyroid Cancer May Be Beneficial |
| 12/20/2011 02:54:13 PM | |
| Obesity Linked to Higher 5-Year Death Rate After Oesophageal Cancer Surgery |
| 12/19/2011 05:29:16 PM | |
| Cancer Survivors Have Increased Risk of Cutaneous Melanoma |
| 12/19/2011 02:52:05 PM | |
| Advantages, Motivations Uncertain Behind Use of Brachytherapy for Breast Cancer |
| 12/19/2011 11:33:02 AM | |
| Rivaroxaban Approved in the EU for the Prevention of AF-Related Stroke, Treatment of DVT |
| 12/17/2011 11:45:46 AM | |
| Deeper Molecular Responses in Patients Taking Nilotinib for Long-Term Chronic Myeloid Leukaemia in Chronic Phase: Presented at ASH |
| 12/16/2011 04:41:08 PM | |
| Long-Term Treatment With Lenalidomide and Dexamethasone Effective and Well Tolerated in Patients With Multiple Myeloma: Presented at ASH |
| 12/16/2011 02:44:50 PM | |
| Safety Profile for Carfilzomib Acceptable for Patients With Late-Stage Multiple Myeloma: Presented at ASH |
| 12/16/2011 01:34:39 PM | |
| EMA Recommends Approval of First-In-Class Treatment for Metastatic or Unresectable Melanoma |
| 12/16/2011 01:30:33 PM | |
| Triple Therapy for Relapsing Multiple Myeloma Falls Short of Expectations in Real-World Study: Presented at ASH |
| 12/16/2011 01:19:40 PM | |
| Deferasirox Reduces Iron Overload in Beta-Thalassaemia Patients not Requiring Transfusions: Presented at ASH |
| 12/16/2011 01:06:41 PM | |
| Multidrug Combination Shows Potent Activity in Newly Diagnosed Multiple Myeloma but With High Toxicity: Presented at ASH |
| 12/16/2011 12:57:21 PM | |
| Response With Carfilzomib/Lenalidomide/Dexamethasone Comparable to Autologous Transplant in Multiple Myeloma: Presented at ASH |
| 12/16/2011 11:32:28 AM | |
| New Test Predicts Risk for Recurrence for Patients With DCIS |
| 12/16/2011 11:31:57 AM | |
| Obesity Linked to Worse Outcomes in Early Breast Cancer Treatment |
| 12/16/2011 11:29:48 AM | |
| Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer |
| 12/15/2011 05:36:08 PM | |
| Panobinostat Shows Promise in Relapsed Multiple Myeloma Patients: Presented at ASH |
| 12/15/2011 03:40:10 PM | |
| Key Genetic Error Identified in Myelodysplastic Syndromes |
| 12/15/2011 02:49:22 PM | |
| Bendamustine Shows Promise in Multiple Myeloma: Presented at ASH |
| 12/15/2011 01:14:02 PM | |
| Adding Bortezomib to Melphalan and Prednisone Shows Overall Mortality Benefit in Multiple Myeloma: Presented at ASH |
| 12/15/2011 12:20:32 PM | |
| Trend for Second Primary Malignancies Among Patients With Multiple Myeloma Requires More Research: Presented at ASH |
| 12/15/2011 11:37:57 AM | |
| Adding Bevacizumab to Chemoradiation Reduces the Spread of Nasopharyngeal Carcinoma |
| 12/15/2011 10:26:13 AM | |
| Health Canada Approves Eribulin for Patients With Metastatic Breast Cancer |
| 12/15/2011 10:23:55 AM | |
| Liberal RBC Transfusion Strategy Offers No Benefit After Hip-Fracture Surgery |
| 12/14/2011 05:29:11 PM | |
| HPV Testing Best Cervical Screening Option for All Women Over the Age of 30 |
| 12/14/2011 02:50:57 PM | |
| Retreatment at Symptomatic Relapse as Effective as Maintenance With Rituximab in Follicular Lymphoma: Presented at ASH |
| 12/14/2011 02:48:57 PM | |
| PFS Benefit With Bortezomib Plus Vorinostat Versus Placebo in Multiple Myeloma Patients: Presented at ASH |
| 12/14/2011 02:46:11 PM | |
| Ruxolitinib Survival, Symptom, and Spleen Size Advantage in Myeloproliferative Syndromes: Presented at ASH |
| 12/14/2011 01:22:52 PM | |
| Faster, Deeper Reponses Shown for Patients With CML-CP Using Nilotinib: Presented at ASH |
| 12/14/2011 12:26:09 PM | |
| Post-thrombotic Syndrome Relieved Through Catheter-Based Treatment: Presented at ASH |
| 12/14/2011 12:22:33 PM | |
| Simple Test Could Help Diagnose Bowel, Pancreatic Cancers |
| 12/14/2011 12:19:14 PM | |
| Gaucher Disease Patients Often Harbour Multiple Myeloma: Presented at ASH |
| 12/14/2011 12:09:35 PM | |
| American Cancer Society Revises Cancer Screening Guideline Process |
| 12/14/2011 10:41:11 AM | |
| Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients |
| 12/13/2011 07:07:00 PM | |
| GA101, Novel Anti-CD20 Agent, Compares Well With Rituximab in NHL: Presented at ASH |
| 12/13/2011 06:11:22 PM | |
| Lenalidomide Maintenance Reduces Risk of Myeloma Progression in Patients Aged 65 to 75 Years: Presented at ASH |
| 12/13/2011 05:20:41 PM | |
| Chemo Without Radiation Therapy Favourable in Limited-Stage Hodgkin's Lymphoma: Presented at ASH |
| 12/13/2011 04:29:58 PM | |
| Patients With Severe Type of Muscular Dystrophy at Increased Risk of Cancer |
| 12/13/2011 01:24:01 PM | |
